Product Information
CAMILA 0.35 MG TABLET is a generic product labeled by Mayne Pharma, priced at $0.0906 per EA under NDC 51862088403. Its NADAC has been published 422 times since Aug 8, 2018.
FDA first approved this application on Oct 21, 2002. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the NORETHINDRONE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.35 mg/1
Manufacturer
Mayne PharmaNDC
51862088403
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
NORETHINDRONEApproval Type
Generic (ANDA)
FDA Application
ANDA076177FDA Approved
10/21/2002
TE Code
AB1
On Market Since
6/15/2018
Pharmacological Classes
Price Statistics
The NADAC for CAMILA 0.35 MG TABLET has been published 422 times since Aug 8, 2018, and over the history we have for it it has declined 62.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0906 per EA |
|---|---|
| All-time high | $0.2803 (Sep 12, 2018) |
| All-time low | $0.0691 (Nov 20, 2024) |
| 52-week high | $0.0945 |
| 52-week low | $0.0849 |
| Median price | $0.1523 |
| Average price | $0.1532 |
| Largest weekly change | +43.4% (Aug 21, 2024) |
| Weeks tracked | 422 |
| Tracking since | Aug 8, 2018 |
1W
N/A
1M
N/A
3M
-3.8%
6M
-4.0%
1Y
-0.7%
3Y
-25.3%
5Y
-49.1%
All
-62.1%
Last surveyed Sep 2, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mayne Pharma manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
NORETHINDRONE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CAMILA 0.35 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAMILA 0.35 MG TABLET, manufactured by Mayne Pharma, is $0.0906 per EA (NDC 51862088403), effective Sep 2, 2026.
How has the price of CAMILA 0.35 MG TABLET changed over time?
Over the history we have for it, the NADAC for CAMILA 0.35 MG TABLET has declined 62.1%. It has been tracked across 422 weekly CMS publications since Aug 8, 2018.
What are the highest and lowest recorded NADAC prices for CAMILA 0.35 MG TABLET?
Since Aug 8, 2018, the NADAC for CAMILA 0.35 MG TABLET has ranged from a low of $0.0691 (Nov 20, 2024) to a high of $0.2803 (Sep 12, 2018), with a median of $0.1523 per EA.
Are there cheaper alternatives to CAMILA 0.35 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CAMILA 0.35 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CAMILA 0.35 MG TABLET?
CAMILA 0.35 MG TABLET (NDC 51862088403) is labeled by Mayne Pharma, and CMS classifies it as a generic product.